Clinical Trial Update: Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on AVX-012 in mild-to-moderate dry eye syndrome across Phase 1 and Phase 2 assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• AVX-012

Snippet

Sponsor: Avizorex Pharma, S.L. | Conditions: Dry Eye Syndrome | Phase 1, Phase 2 | Status: UNKNOWN